Uniall Pharma Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2010.
2010 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Uniall Pharma Private Limited

Uniall Pharma Private Limited, a active private limited company, was established on 27 April 2010 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the professional, scientific and technical sector, it holds CIN: U15400MH2010PTC202431. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Jitendra Patel Kumar (Director), Abutalib Khan (Director), Deepak Kumar Mishra (Director). Past directors included Rajesh Tiwari. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shivaji Nagar, Room No. 2A8, Govandi,, Mumbai, Maharashtra, 400043.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U15400MH2010PTC202431

  • Registration Number

    202431

  • Incorporation Date

    27 April 2010

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 15 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** 16.86%
  • Profit Growth **** 41.58%
  • Ebitda **** -455.10%
  • Net Worth -2.30%
  • Total Assets **** 12.76%
Company report

Uniall Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Uniall Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Uniall Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Jitendra Patel Kumar Director 27 Apr 2010 Current
Abutalib Khan Director 27 Apr 2010 Current
Deepak Kumar Mishra Director 27 Apr 2010 Current
Chandrahas Ghodki Director 27 Apr 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Aug 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Uniall Pharma.

Uniall Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.86% increase. The company also saw a substantial improvement in profitability, with a 41.58% increase in profit. The company's net worth dipped by a decrease of 2.3%.

Uniall Pharma revenue growth over time
Uniall Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 16.86%
*******
*******
*******
*******
Revenue from Operations
*******
 16.97%
*******
*******
*******
*******
Total Assets
*******
 12.76%
*******
*******
*******
*******
Profit or Loss
*******
 41.58%
*******
*******
*******
*******
Net Worth
*******
 -2.30%
*******
*******
*******
*******
EBITDA
*******
 -455.10%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Uniall Pharma?

In 2020, Uniall Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Uniall Pharma?

Unlock and access historical data on people associated with Uniall Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Uniall Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uniall Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Uniall Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Uniall Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Uniall Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    The activity Jitendra Patel Kumar was appointed as a Director was appointed as a Director on 27 Apr 2010 & has been associated with this company since 15 years 9 months . was completed.

  • Director Appointment

    The activity Abutalib Khan was appointed as a Director was appointed as a Director on 27 Apr 2010 & has been associated with this company since 15 years 9 months . was completed.

  • Director Appointment

    Progress on Deepak Kumar Mishra was appointed as a Director was appointed as a Director on 27 Apr 2010 & has been associated with this company since 15 years 9 months . was documented.

  • Director Appointment

    The activity Chandrahas Ghodki was appointed as a Director was appointed as a Director on 27 Apr 2010 & has been associated with this company since 15 years 9 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Uniall Pharma Private Limited?

The CIN of Uniall Pharma Private Limited is U15400MH2010PTC202431.

Where is Uniall Pharma Private Limited headquartered?

Uniall Pharma Private Limited is headquartered at Shivaji Nagar, Room No. 2A8, Govandi,, Mumbai, Maharashtra, 400043.

When was Uniall Pharma Private Limited incorporated?

Uniall Pharma Private Limited was incorporated on 27 April 2010.

Who are the current directors of Uniall Pharma Private Limited?

The current directors of Uniall Pharma Private Limited are

What is the primary industry of Uniall Pharma Private Limited?

The primary industry of Uniall Pharma Private Limited is Professional, Scientific And Technical.

Is Uniall Pharma Private Limited a listed company?

Uniall Pharma Private Limited is unlisted.

What is the capital structure of Uniall Pharma Private Limited?

The authorized capital of Uniall Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Uniall Pharma Private Limited?

The compliance status of Uniall Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available